Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants

By sjmartinez • October 23, 2023

Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Lee E, Der-Torossian C, Gupta R, Berry M, Hollemeersch S, Kalil AC. Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants. Open Forum Infect Dis. 2023 Sep 22;10(10):ofad482. doi: 10.1093/ofid/ofad482. PMID: 37869410; PMCID: PMC10588622.

Tags: comparative effectiveness research, covid-19, Hospitalization, mortality, Publications, Pulmonary, Critical Care & Sleep Medicine, remdesivir

Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study

Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa[...]

Homelessness and Risk of End-Stage Kidney Disease and Death in Veterans With Chronic Kidney Disease

Koyama AK, Nee R, Yu W, Choudhury D, Heng F, Cheung AK, Cho ME, Norris KC, Yan G. Homelessness and Risk of End-Stage Kidney Disease[...]

Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease

Galindo RJ, Soliman D, Cherñavvsky D, Rhee CM. Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease. Diabetologia. 2024 Sep 10. doi:[...]